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Abstract: Zinc plays critical roles during embryogenesis, fetal growth, and milk secretion, 
which increase the zinc need for pregnancy and lactation. Increased needs can be met by 
increasing the dietary zinc intake, along with making homeostatic adjustments in zinc 
utilization. Potential homeostatic adjustments include changes in circulating zinc, increased 
zinc absorption, decreased zinc losses, and changes in whole body zinc kinetics. Although 
severe zinc deficiency during pregnancy has devastating effects, systematic reviews and 
meta-analysis of the effect of maternal zinc supplementation on pregnancy outcomes have 
consistently shown a limited benefit. We hypothesize, therefore, that zinc homeostatic 
adjustments during pregnancy and lactation improve zinc utilization sufficiently to provide 
the increased zinc needs in these stages and, therefore, mitigate immediate detrimental 
effects due to a low zinc intake. The specific questions addressed are the following: How is 
zinc utilization altered during pregnancy and lactation? Are those homeostatic adjustments 
influenced by maternal zinc status, dietary zinc, or zinc supplementation? These questions 
are addressed by critically reviewing results from published human studies on zinc 
homeostasis during pregnancy and lactation carried out in different populations worldwide. 
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Zinc is widely recognized for its critical roles in cell division, differentiation and function that are 
essential for tissue growth. Zinc-dependent enzymes, zinc-binding factors and zinc transporters are 
required in a variety of complex mechanisms during cell replication, maturation and adhesion, such as 
DNA and RNA metabolism, signal recognition and transduction, gene expression, and hormone 
regulation [1–3]. Consequently, zinc is a key nutrient during embryogenesis, fetal growth and 
development, and mammary gland function for milk synthesis and secretion. 
Severe zinc deficiency during pregnancy and lactation has devastating effects on pregnancy outcome, 
as shown in animal studies and in pregnant women with acrodermatitis enteropathica [4]. Multiple 
fetal malformations, embryonic or fetal death, fetal growth retardation and life-threatening maternal 
complications during pregnancy and labor have been described. Although severe zinc deficiency is 
rare worldwide, mild to moderate zinc deficiency is highly prevalent in pregnant and lactating women 
in several geographic regions [5]. It has been estimated that 82% of pregnant women in the world have 
insufficient zinc intakes [6]. Sub-adequate maternal zinc intakes may affect pregnancy outcomes and 
infant development. However, it is surprising to note that human observational studies have failed to 
find associations between poor maternal zinc status or intake and pregnancy complications, duration of 
gestation, and measurements of fetal growth and development. Moreover, systematic reviews and 
meta-analyses of the effect of maternal zinc supplementation on pregnancy outcomes (see below) have 
not shown a health benefit of zinc supplementation during pregnancy. 
There have been numerous observational human studies relating maternal zinc status and maternal 
and fetal outcomes. Most of them have been summarized in previous reports [4,7,8]. Studies relating 
maternal zinc status and maternal complications such as pregnancy-induced hypertension, premature 
rupture of membranes, placental abruption and prolonged labor, primarily published between 1980 and 
2000 are inconclusive: significant associations were found in about half of the studies; the other half 
found no relationship [8]. In particular, in the study with the largest number of pregnant women  
(n = 3448), no significant associations were found between plasma zinc and preterm delivery, 
hypertension, amnionitis, or postpartum infection [9]. 
More observational studies related maternal zinc status to infant birth weight than to any other 
pregnancy or infant outcome, possibly because birth weight is a continuous variable that can be studied 
in smaller sample sizes. Of the 41 observational studies done during nearly two decades (1977 to 
1994), only 17 studies found an association between poor maternal zinc status and low birth weight or 
retarded fetal growth, with both types of results equally distributed among developing and developed 
countries thus not showing a geographic pattern [4]. However, more recent studies appear to support a 
relationship between maternal zinc status or intake and infant birth weight. A study in Tanzania found 
that mothers with low plasma zinc at delivery were two and a half times more likely to have an infant 
with a birth weight <2000 g compared to mothers with normal zinc levels [10]. Also, in Korea 
maternal zinc intake from animal sources at mid-pregnancy was positively associated with infant birth 
weight and height [11]. In contrast, a study in Iranian pregnant women found an inverse relationship 
between maternal serum zinc at delivery and neonatal birth weight [12]. 
Zinc supplementation studies of pregnancy and infant outcomes have been addressed in a number 
of review articles, systematic reviews, and meta-analyses [4,6,8,13–18]. These critical evaluations 
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show no evidence that routine zinc supplementation during pregnancy prevents maternal complications 
during pregnancy and delivery. Also, most supplementation trials did not find a significant effect of 
zinc supplementation on infant birth weight, length or head circumference. However, a meta-analysis 
of zinc supplementation trials found a 14% reduction in premature delivery among zinc-supplemented 
women [15]. A subsequent systematic review of 20 independent intervention trials also found that the 
risk of preterm birth was significantly reduced with maternal zinc supplementation, but zinc 
supplementation had no effect on fetal growth [18]. However, the strength of the evidence for a 
positive effect of zinc supplementation on preterm birth was graded low. The authors speculated that 
supplemental zinc reduced maternal infections, a primary cause of prematurity. 
Most studies finding a positive effect of maternal zinc supplementation on infant birth weight and 
other infant parameters were done in underweight or zinc-deficient women [16]. For example, in an 
Indian study mothers receiving supplemental zinc had longer gestational ages and higher birth  
weights [19]. Also, in a study of rural Chinese pregnant women receiving increasing levels of zinc 
supplement or placebo, those receiving the highest zinc dose (30 mg/day) had infants with higher birth 
weights and larger head circumferences than those in the placebo group [20]. In a study of  
African-American pregnant women living in the USA without health-care coverage, zinc 
supplementation (25 mg/day) during the second half of pregnancy significantly increased infant birth 
weight and head circumference [21]. Only women with plasma zinc below the median for the 
population at 20 week of gestation were included in the study. Among the women with low plasma 
zinc concentrations, the effect was more pronounced in non-obese (BMI < 26 kg/m2) women. However, 
when underweight Bangladeshi urban poor pregnant women with low BMIs (mean = 18.9 kg/m2) were 
given supplemental zinc (30 mg/day) for the last two trimesters, no effect was seen on infant birth 
weight, gestational age, infant length or other infant measurements [22]. 
Several factors may account for the lack of consistency between studies, i.e., the lack of a reliable 
zinc status index, insufficient sample size, variable timing and duration of zinc supplementation, 
maternal weight status, maternal age, maternal gastrointestinal disease, dietary factors affecting zinc 
bioavailability, and the co-existence of multiple micronutrient deficiencies [4,14,16]. Differences in 
the capacity to adapt zinc metabolism physiologically during pregnancy and lactation when maternal 
zinc status is limiting may be another factor [4]. Possible physiologic adjustments in zinc metabolism 
during pregnancy and lactation include changes in tissue zinc distribution, increased zinc absorption, 
reduced endogenous zinc losses, and changes in the exchangeable zinc pools kinetics. Studies of these 
zinc metabolic adjustments done in women with differing zinc intakes provide an opportunity to 
determine the impact of maternal zinc intakes on homeostatic adjustments of pregnancy and lactation. 
We hypothesize that the homeostatic adjustments of zinc utilization during pregnancy and lactation 
are influenced by maternal dietary zinc intakes. Therefore, we review the relationship between 
maternal zinc intake and the various homeostatic changes normally occurring during pregnancy and 
lactation to the extent possible from the data available.  
2. Zinc Homeostasis during Pregnancy 
Zinc requirements for pregnant women have been estimated from the amount of zinc accumulated 
in maternal and embryonic/fetal tissues using the factorial approach [23]. Of about 100 mg of total zinc 
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gained by pregnant women, 57% is accrued in the fetus, 6.5% in the placenta, <1% in the amniotic 
fluid, 24% in the uterus, 5% in mammary tissue, and 6.5% in the expanded maternal blood volume. 
This additional zinc gained for pregnancy represents ≈5%–7% of the whole-body zinc in a  
non-pregnant woman [4]. 
Depending on the zinc bioavailability in the habitual diet of the pregnant woman, about 2 to 4 mg of 
additional dietary zinc is needed daily to meet these additional needs [5,24]. This translates into  
18%–36% more zinc per day in the diets of pregnant compared to non-pregnant women. However, 
irrespective of their usual zinc intake, most women do not report increased intakes of dietary zinc 
during pregnancy [4]. This suggests that homeostatic adjustments are the primary mechanisms for 
meeting the increased zinc requirements of pregnancy [4]. 
Maternal and Cord Blood Zinc Levels. The distribution of zinc among the various blood 
components changes during pregnancy [7,25,26]. Plasma or serum zinc concentration declines  
15%–35% by late pregnancy compared to pre-pregnancy or early pregnancy concentrations [9,26–31]. 
This decline in plasma zinc levels is related to the plasma volume expansion, which increases about 
40% by 30 weeks gestation [32]. Erythrocyte zinc concentrations increase 10%–15% during pregnancy 
even though the erythrocyte volume also increases [28,29,31,33]. Because plasma and erythrocyte 
volume increases during pregnancy, the total zinc mass in the plasma and erythrocytes is higher in 
pregnant, than in nonpregnant women [25]. 
The decline in plasma zinc concentration during pregnancy is considered a physiological response 
to pregnancy, due to hemodilution, hormonal changes, increased urinary zinc excretion, increased zinc 
uptake by maternal tissues, and active maternal-fetal transfer of zinc [7,25]. In addition, the percent of 
total serum zinc bound to albumin [34], and the affinity of zinc for serum albumin [35], are lower in 
pregnant compared to non-pregnant women. This also contributes to the decline in total circulating 
zinc concentrations during pregnancy and, may facilitate zinc uptake by the placenta and maternal 
tissues such as bone marrow and liver. 
The increase in erythrocyte zinc concentration during pregnancy is mainly due to an increased 
synthesis of the zinc-dependent enzyme, carbonic anhydrase, to ensure metabolism of the carbon 
dioxide produced by the developing fetus [23]. Erythrocyte metallothionein also increases 9%–11% 
during pregnancy [33,34]. Metallothioneins are low-molecular-weight, cysteine-rich, zinc-binding 
proteins, expressed specifically in tissues. Metallothioneins have a number of complex cellular 
functions, including gene expression, proliferation and differentiation, regulating intracellular zinc 
homeostasis, and mitigating oxidative stress [3,36,37]. The increase in erythrocyte metallothionein 
during pregnancy may reflect increased cellular zinc needs such as protecting maternal erythrocytes 
from the oxidation stress associated with the increased oxygen demand of gestation. 
Cord blood plasma/serum zinc concentration is consistently higher than corresponding levels in 
maternal blood with a mean maternal/cord ratio of about 0.7 [7,33,38]. However, cord blood 
erythrocyte zinc is about one-third or less than maternal concentrations with an average maternal/cord 
ratio of about 3 [7,33,38]. In vitro studies of human placentae and animal models [39–42] show that 
placental zinc uptake and release involves an active and highly regulated process. Thus, cord serum 
zinc concentrations remain relatively constant at about 14 μmol/L over a wide range of maternal serum 
zinc concentrations (6.0–15.6 μmol/L) [38]. 
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The stage of gestation may affect the rate of zinc uptake by the placenta. An in vitro study of zinc 
uptake by microvillous membrane vesicles from preterm and term placentas of Brazilian women 
showed that the uptake was higher in preterm than term vesicles. Also, maternal plasma zinc 
concentrations appeared to influence placental zinc uptake. In the term vesicles, zinc uptake was 
higher when women in the lowest quartile of serum zinc were examined compared to the highest 
quartile (p < 0.05) [41]. These results suggest that the placenta has some capacity to adapt the rate of 
zinc uptake to fetal needs such as more rapid growth rates in earlier gestation and when maternal zinc 
status is low. The mechanism for placental zinc transport is unknown, but it probably involves 
placental zinc transporters and metallothionein. Also, there is a limit to the adaptation since offspring 
born to zinc-depleted rats are stunted and have multiple congenital anomalies [4]. 
Effect of Maternal Zinc Intake on Maternal and Cord Blood Zinc Levels. The effect of pregnancy 
on plasma zinc levels has been studied in populations routinely consuming diets that differ in zinc. The 
largest study was done in pregnant American women (n = 3448) of low socio-economic background, 
mixed ethnicity, and non-users of zinc supplements [9]. Plasma zinc declined rapidly between 8 and  
22 weeks of gestation reaching a plateau during late pregnancy. Dietary zinc was not measured in that 
study. A similar decline was seen in American women of middle-income background who reported 
consuming about 11 mg zinc/day [27,30]. The plasma zinc decline was not prevented by zinc 
supplementation (15 mg/day) during pregnancy [27], suggesting that the decline was not due to 
insufficient dietary zinc.  
In contrast, Peruvian women accustomed to a low zinc diet (≈7 mg/day) had a steeper decline than 
that described in more zinc-replete populations [26]. Moreover, Peruvian mothers supplemented during 
pregnancy with zinc (15 mg/day), along with iron plus folate, had higher serum zinc concentrations by 
late pregnancy compared to those not receiving supplemental zinc. After adjusting for covariates and 
confounding factors, cord serum zinc was also higher in neonates of mothers receiving supplemental 
zinc. However, the increase in maternal and cord serum zinc was small (≈5%), and their serum zinc 
concentrations were lower than the average values reported for American women [9]. Cord serum zinc 
concentrations also were lower than values reported in other populations with higher zinc 
intakes [38,43]. These data suggest that zinc supplementation has a small effect on maternal plasma 
and cord blood zinc concentrations, and there was no effect on infant birth weight or other body-size 
measurements [44]. In a subsequent study in Peruvian women the mothers were given a higher zinc 
supplement, 25 mg/day of zinc with iron/folate. Maternal plasma zinc declined during pregnancy 
irrespective of supplemental zinc. Zinc supplementation increased maternal erythrocyte zinc (but not 
erythrocyte metallothionein) compared to unsupplemented women (p < 0.04) [33], but erythrocyte zinc 
in the cord blood was unchanged. Studies of the infants at 4 to 12 months of age showed that those 
infants born to mothers receiving supplemental zinc had significantly higher measures of lean tissue 
mass accretion [45]. However, no effects of maternal zinc supplementation on child cognitive, social, 
or behavioral development were detected at 4.5 year of age [46]. These data suggest that providing 
25 mg supplemental zinc to pregnant women with low habitual zinc intakes has a limited effect on 
maternal zinc status during pregnancy and the offspring’s development. However, comprehensive studies 
of the potential effect of maternal zinc supplementation on immune function and health are needed.  
Regulation of Zinc Homeostasis in Pregnancy. The 24 zinc transporters are major factors involved 
in zinc homeostasis regulation; ten transporters are from the ZnT family and 14 from the Zrt-, Irt-like 
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protein (ZIP) family [47]. The ZnT proteins efflux zinc from the cytoplasm either across the cell 
membrane or intracellular vesicles; the ZIP proteins import zinc into the cytoplasm. The expression of 
ZnT1and ZnT4 was found in rat placenta [42], and that of ZnT1, ZnT4, ZnT5, ZnT7 and ZIP1 was 
found in mouse placenta [48]. In mouse, placental zinc transporter expression responded to changes in 
dietary zinc; ZnT1, ZnT4 and ZIP1 were down-regulated with both zinc restriction or excess, and 
ZnT5 was reduced with zinc excess [48]. In the human placenta, ZnT1–8 and ZIP1 were detected in 
trophoblast Be Wo cells [49], and ZnT1 and ZnT5 were detected in villous syncytiotrophoblast 
cells [48]. Although zinc transporter expression has been measured in human placenta, the regulatory 
role of these transporters in the transfer of zinc from the mother to the fetus is unknown. 
Human placental metallothionein has been measured in several studies using different  
methods [33,38,50–53]. For example, metallothionein levels were measured in maternal and cord 
erythrocytes and placental tissue from Peruvian and Brazilian women with habitual zinc intakes of  
8 and 11.5 mg/day, respectively (Figure 1). The Peruvian women with lower zinc intakes had 
significantly lower maternal erythrocyte metallothionein and higher placental metallothionein 
concentrations compared to the Brazilian women. The increased levels of placental metallothionein 
along with a reduction in erythrocyte zinc in the women with lower zinc intakes may reflect a shift in 
tissue zinc levels from the mother to the placenta to potentially improve fetal zinc transfer. However, 
this adaptation did not equalize cord blood erythrocyte metallothionein levels in the Peruvian and 
Brazilian women. Comprehensive studies on the effect of maternal dietary zinc on fetal transfer of 
zinc, placental metallothionein and zinc transporters are needed. 
Figure 1. Maternal and cord blood erythrocyte (RBC), and placental metallothionein (MT) 
at delivery, in Peruvian and Brazilian women. Peruvian women (□): n = 158 (maternal 
erythrocytes) and n = 30 (placenta and cord blood erythrocytes) [33]. Brazilian women (■): 
n = 40 (erythrocytes and placenta) [38]. Comparison of each variable between groups was 
done by t-test. All comparisons were significant (p < 0.05). 




























Urinary Zinc. The renal handling of zinc during pregnancy may be influenced by maternal zinc 
intake. Among women consuming ≥11 mg zinc/day, urinary zinc excretion increased about two-fold at 
late pregnancy compared to early pregnancy or preconception [27,30,54]. This increase in urinary zinc 
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is attributed to the increased glomerular filtration rate typically occurring during pregnancy. However, 
this increase was not seen in women with lower zinc intakes (7 to 9 mg/day) [26,31] suggesting that 
renal zinc conservation may occur when maternal zinc intakes are low. However, since the daily 
urinary zinc excretion is low, renal conservation of urinary zinc will have a minor effect on zinc 
retention, at most about 0.3 mg of zinc/day [4]. 
Intestinal Zinc Absorption. Stable zinc isotopes have been used to study the effect of pregnancy on 
intestinal zinc absorption in a diverse group of women [30,31,55,56]. Two longitudinal studies of zinc 
absorption were done in women with habitual zinc intakes of 12 mg/day (Californian women) [30] or  
9 mg/day (Brazilian women) [31] using a double isotopic tracer for measuring fractional zinc 
absorption from a standard breakfast meal (Figure 2). In the Californian women consuming about  
12 mg zinc/day, the increase in intestinal zinc absorption from pre-pregnancy (14.6%) to late 
pregnancy (19.4%) was not significant. Among the Brazilian women routinely consuming 9 mg 
zinc/day, fractional zinc absorption increased significantly (p < 0.05) from early (29%) to late (43%) 
pregnancy. These data suggest that the efficiency of zinc absorption may increase with lower zinc 
intakes during late pregnancy. In a group of zinc supplemented Peruvian women, fractional zinc 
absorption from a flavored drink averaged 47% [55] and was similar to that of the Brazilian  
women [31]. If we assume that the measured zinc absorption from the breakfast meal is similar to that 
of the whole diet, the net increase in fractional absorption at late pregnancy would increase the amount 
of absorbed zinc by about 1.3 mg/day [31]. However, differences in the amount of zinc absorbed from 
a breakfast meal compared to that of the whole diet are unknown. Moreover, the Brazilian study was 
not powered to assess the relationship between absorbed zinc and functional health outcomes. 
Figure 2. Percent zinc absorption during pregnancy and lactation in Californian and 
Brazilian women. Californian women (□), n = 13 [30]. Brazilian women (■), n = 8 [31]. 
Means within each group with different superscript letters are significantly different by 
repeated measures ANOVA and Tukey’s range test, p < 0.05. 
























Hambidge and co-workers measured zinc absorption from the whole diet in a group of Ethiopian 
pregnant women habitually consuming about 6 mg/day. Fractional zinc absorption averaged 35%, and 
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the total amount absorbed averaged 2.1 mg/day. Although the amount of zinc absorbed was about 16% 
higher than that of non-pregnant Ethiopian women, this amount was still considered insufficient to 
meet the increased zinc needs for late pregnancy [56]. 
Zinc Kinetics. Two groups examined parameters of zinc kinetics in pregnant women [31,56]. Both 
studies were done in women habitually ingesting low zinc diets (<10 mg/day). In the study of Brazilian 
women, the size of the combined zinc pools exchanging with plasma zinc within 24 h averaged about 
50 mg and did not change significantly between 10–12 and 34–36 weeks of gestation [31]. In the study 
of Ethiopian women in their third trimester of pregnancy, the size of the combined zinc pools 
exchanging with plasma over 72 h averaged 142 mg, or about 47 mg/24 h, which is similar to the 
exchange rate in the Brazilian women [56]. Among the Brazilian women, the net flux of zinc from the 
plasma into the exchangeable pool increased 53% between 10–12 and 34–36 weeks pregnancy. This 
represents a 75 mg increase in the amount of zinc transferred to the fetus and maternal tissues with 
increased metabolic rates in late pregnancy, i.e., the liver, kidney, and bone marrow [31]. Further 
studies are needed to determine the effect of maternal dietary zinc on zinc kinetics to the conceptus and 
other tissues during different stages of pregnancy. 
Summary of the Effect of Maternal Dietary Zinc on Homeostatic Adjustments of Pregnancy. 
Although the data are limited, the following conclusions can be drawn regarding the relationship 
between maternal dietary zinc and homeostatic adjustments: 
• Plasma zinc declines during pregnancy with a larger decline seen in women with habitual intakes 
≤9 mg/day. 
• Renal zinc conservation increases among women with low intakes, ≤9 mg/day, but the net 
increase in zinc retention is very small (≤0.3 mg/day). 
• Fractional zinc absorption appears to increase when the maternal zinc intake falls below  
9 mg/day, but the net increase in absorbed zinc does not appear to be sufficient to meet the 
increased zinc needs for pregnancy when dietary zinc is very low (≤6 mg/day). 
• Endogenous fecal zinc losses have not been measured in human pregnancy, thus it is not known 
if these losses vary with dietary zinc. 
• Preliminary kinetic data suggest that the flux of zinc from the exchangeable zinc pools to other 
tissues may increase in pregnancy. 
• The regulatory role of zinc transporter proteins and metallothioneins in the placental zinc 
transfer needs further investigation. 
3. Zinc Homeostasis during Lactation 
Dietary zinc requirements during lactation are estimated from the amount of zinc secreted in breast 
milk after adjusting for the availability of zinc from uterine and maternal blood volume involution 
following delivery. Although the zinc concentration in breast milk declines during the first six months, 
the average requirement for absorbed zinc is 1.35 mg/day [24]. The additional zinc need for a  
six-month period of exclusive breast-feeding is approximately 227 mg, more than double the amount 
required during pregnancy. If one assumes that zinc absorption averages 27%, this additional need 
translates to an additional intake of 4 mg zinc/day, a 50% increase compared to non-pregnant  
non-lactating women [24]. 
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Because lactation zinc demands are high, lactation puts a significant stress on maternal physiological 
mechanisms to maintain zinc homeostasis, particularly during the early weeks post-partum. Milk zinc 
secretion averages 2–3 mg/day during the first month, declines to about 1 mg/day by 3 months, and 
continues to decline thereafter to about 0.5 mg/day [57]. The high zinc needs in early lactation may be 
met partially by mobilizing maternal zinc pools from involuting tissues after delivery (uterus and 
maternal blood) [24] and trabecular bone [57,58]. Bone resorption increases during early lactation 
before menstruation is re-established and maternal estrogen levels are low [59]. It has been estimated 
that about 30 mg of zinc, or about 1 mg/day, can be released from involuting maternal tissues during 
the first month of lactation [24]. The amount of zinc released from maternal bone during lactation has 
not been measured. But, approximately 30% of total body zinc is in bone tissue, and it is estimated that 
about 4%–6% of maternal bone mass is lost during 6 months of full lactation enabling maternal bone 
to contribute about 20% of the breast milk zinc over a 6 month period [58]. 
Maternal Blood Zinc Levels in Lactation. In spite of the transfer of maternal circulating zinc to the 
mammary gland, maternal plasma zinc concentrations return to pre-pregnancy or early pregnancy 
levels within the first few weeks postpartum [30,31,60]. The milk/maternal plasma zinc concentration 
ratio is very high (4 fold or higher) during the first month of lactation; it drops to about 2 fold by  
3 months, and about 1.5 fold at 6 months of lactation [61]. Animal studies and cell models indicate that 
an α-2-macroglobulin receptor in the mammary gland epithelial cells facilitates zinc uptake and 
transfer into milk [62]. Zinc importers (Zip3) and zinc exporters (ZnT-1, ZnT2, and ZnT4) localized in 
the alveolar lumen and other cells [42,63,64] also play a role in regulating milk zinc concentration 
throughout lactation. 
Maternal Zinc Intakes and Breast Milk Concentrations. As mentioned earlier, longitudinal studies 
show that breast-milk zinc concentration decline over time in American [61,65], Egyptian [66], 
Brazilian [67], and Finish [68] women. Cross-sectional studies of milk zinc concentrations in The 
Gambia [69], Nigeria [70], India [71], and Honduras [72] also show a decline in milk zinc 
concentration with time. Although measures of maternal zinc intake are not available from all of these 
populations, the data show a similar declining trend in milk zinc concentration among very different 
populations of women who likely had different levels of zinc intake. 
However, when milk zinc concentrations of women from developing countries are compared to 
women from developed countries, women from developing countries frequently have lower zinc milk 
concentrations suggesting that maternal zinc intakes or status influence breast milk zinc  
concentrations [57]. Studies in lactating mice show that marginal zinc deficiency reduced the 
mammary gland zinc secretory capacity and lowered milk zinc concentration [73]. But, higher milk 
zinc concentrations among women from developing compared to developed countries has also been 
reported. For example, the milk zinc concentrations in Gambian [69] and Indian [71] women were 
higher than those in the United Kingdom [69] and USA [74] women. Also, milk zinc concentration at 
9 months postpartum was over 50% higher in lactating women from Honduras compared to those from 
Sweden [72]. A decrease in milk fluid could lead to an increase in zinc concentration. Also, since 
breast milk zinc is usually associated with proteins, a shift in the amount or type of milk proteins could 
also influence milk zinc concentrations. Further studies are needed to fully identify the factors 
influencing breast milk zinc concentrations. 
Nutrients 2012, 4 791 
 
 
Although several groups have reported that maternal zinc supplementation slows the rate of decline 
in milk zinc concentration during lactation [66,68,74], no one has found a correlation between 
maternal zinc intake or plasma zinc, and milk zinc concentration among women in developed and 
developing countries [28,61,72,75,76]. It appears that maternal zinc intake or status has a minor effect 
on breast milk concentrations. This is consistent with an efficient mammary gland up-regulation of 
zinc transporters to maintain milk zinc concentrations over a range of maternal zinc intakes as 
observed in animal studies [77]. The combined effect of poor zinc intakes and sub-clinical infections in 
lactating women on milk zinc levels needs further testing as the plasma stress-mediated zinc carrier 
proteins, such as α-2 macroglobin, appear to influence mammary gland zinc uptake and secretion [62]. 
Maternal Urinary Zinc Excretion during Lactation. Several groups have studied the effect of 
lactation on urinary zinc excretion [30,31,61,74,78]. Despite differences in dietary zinc intake among 
the populations studied, urinary zinc excretion declined to pre-pregnancy or early pregnancy levels at 
7–9 weeks postpartum in lactating Californian [30] and Brazilian [31] women. However, there is some 
evidence that urinary zinc levels are lower in lactating than in non-lactating postpartum women in spite 
of consuming more zinc (13 mg/day compared to 10 mg/day) [78]. Also, urinary zinc excretion was 
lower in lactating women consuming 11 mg zinc/day than that in non-pregnant non-lactating controls, 
during 10 months of lactation [74]. However, others have failed to find reductions in urinary zinc 
among lactating women with low zinc intakes [31,79,80]. In any case, the magnitude of the renal zinc 
economy is relatively small, about 8% of the total milk zinc output over 6 months [78]. 
Intestinal Zinc Absorption during Lactation. Isotopic tracer studies have been used to measure zinc 
absorption during lactation [30,31,79–81]. In contrast to studies of zinc absorption in pregnancy, all 
studies consistently show increased zinc absorption during lactation compared to preconception [30], 
early pregnancy [31], never-pregnant women [80], or non-lactating post-partum women [81]. An 
increase in the efficiency of zinc absorption seems to be a primary means to increase zinc retention 
during lactation. Animal studies suggest that this increase may be due to an increase in the length of 
the intestine [82]. 
In the two longitudinal studies of zinc homeostasis during pregnancy and lactation (Figure 2), 
fractional zinc absorption increased 1.7 fold from pre-conception to lactation in Californian women 
consuming about 12 mg zinc per day [30] and 1.4 fold from early pregnancy to lactation in Brazilian 
women consuming about 9 mg zinc per day [31]. In the Brazilian women, fractional zinc absorption 
was inversely related to plasma zinc concentrations (r = −0.73; p = 0.02), suggesting that plasma zinc 
levels may influence zinc absorption during lactation. Animal studies indicate that dietary zinc 
deficiency causes up-regulation of Zip4 expression in the apical membrane of enterocytes [2]. Further 
studies on the relationship between maternal zinc intake or status and zinc absorption during lactation 
are needed to confirm this potential relationship. 
The capacity to maintain breast milk zinc concentration with low maternal zinc intakes may be due 
to a marked increase in fractional zinc absorption. Cross-sectional studies show that lactating women 
consuming diets low in zinc have higher fractional zinc absorptions than women with adequate zinc 
intakes. For example, the fractional zinc absorption ranged from 0.59 to 0.84 in seven lactating women 
in the Amazon valley with a mean zinc intake of 8.4 mg/day [79]. In another study of 18 rural Chinese 
women with a mean zinc intake of 7.6 mg/day, fractional zinc absorption averaged 0.53, which was 
71% higher than the zinc absorption in never-pregnant women from the same community [80]. Total 
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zinc absorption was about 2.4 mg/day higher in the lactating than the never-pregnant women, which 
was sufficient to provide the estimated net loss of 2 mg of zinc/day in breast milk. These investigators 
also found that endogenous fecal zinc excretion was reduced in the lactating women compared to the  
never-pregnant group. 
Zinc Kinetics during Lactation. Two groups have studied zinc kinetics in Brazilian lactating women 
consuming either 8.4 or 9 mg zinc per day [31,79]. Among the women from the Amazon Valley, the 
size of the exchangeable pool that equilibrated with the isotopic tracer over five days was 244 mg [79]. 
The exchangeable pool averaged 52 mg after a short 24-h equilibration period in the women from Rio 
de Janeiro [31]. If one extrapolates this exchangeable zinc pool size to a five-day equilibration period, 
the estimated size is 260 mg, a value very similar to that found in the Amazonia women. Further 
studies are needed to determine the effect of maternal dietary zinc on zinc kinetics of the mammary 
gland and other maternal tissues during different stages of lactation. 
Summary of Maternal Dietary Zinc and Homeostatic Adjustments during Lactation. The data 
regarding the effect of maternal dietary zinc on zinc homeostasis in lactating women are very limited. 
However, the following preliminary conclusions can be drawn: 
• Milk zinc concentration and milk zinc output declines about 75% over the lactation period 
irrespective of maternal zinc intake. 
• Limited evidence suggests that milk zinc concentration is reduced with low zinc intakes. 
• Renal zinc conservation occurs during lactation, largely independent of maternal zinc intake, but 
the net effect on zinc conservation is small. 
• The efficiency of zinc absorption increases during lactation. The net change is further enhanced 
with low zinc diets (≤8 mg/day) or when maternal zinc status is marginal. Endogenous fecal zinc 
excretion may also decline among lactating women with low zinc intakes. 
• The effect of low maternal zinc intakes on zinc kinetics and the regulation of mammary gland 
zinc uptake and secretion are unknown. 
4. Other Research Implications 
In this review we focused on the effect of maternal zinc intake on zinc homeostasis during 
pregnancy and lactation. However, a number of other factors may also influence the homeostatic 
adjustments during the human reproduction cycle. For example, the continuum from pre-pregnancy to 
pregnancy to lactation has not been studied. It is possible that the homeostatic adjustments during 
pregnancy reflect the mother’s zinc status prior to conception and that the lactation adjustments reflect 
zinc status during pregnancy. In a study of lactating Spanish women, maternal zinc intake during late 
pregnancy influenced mature milk zinc concentrations [83]. This continuum needs further study. 
Low zinc diets are usually also poor in iron, vitamin B12, vitamin A, and other micronutrients, due 
to lack of animal protein foods. The co-existence of multiple micronutrients deficiencies during 
pregnancy and lactation, frequently seen in developing countries [84], may limit the maternal capacity 
to maintain zinc homeostasis. The effect of multiple micronutrient deficiencies on zinc homeostasis 
during pregnancy and lactation is unknown. For example, low dietary calcium intake and vitamin D 
status, which are common in many countries [85], may increase bone resorption and the release of 
bone zinc during pregnancy and lactation whereas the use of supplemental calcium and vitamin D 
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could limit bone zinc release. Use of micronutrient supplements not including zinc may further impair 
physiologic adaptation. For example, fractional zinc absorption was reduced with use of supplemental 
iron in pregnancy [55] and in lactation [86]. 
Environmental exposure to toxic substances (i.e., heavy metals, pesticides, dioxin, polycyclic 
aromatic hydrocarbons, nicotine, etc.) and to infectious agents (i.e., HIV and other sexually transmitted 
infections, tuberculosis, malaria, intestinal parasites, etc.), are known to interfere with zinc  
homeostasis [3,52,53,87–90]. The presence of an infection among pregnant or lactating women with 
low zinc intakes could divert limited tissue zinc to meet the high demand of the immune system [91] 
making less zinc available for the fetus or mammary gland. It is known that plasma zinc declines as 
part of the acute-phase response to infection to enable several aspects of the immune response  
(i.e., recruitment of neutrophils, natural killer cell activity, and phagocytosis of macrophages) [91]. 
Studies of well-nourished pregnant women show that the leukocytic zinc concentrations decrease 
during the second half of pregnancy [92]. Also, zinc deficiency during pregnancy increases 
susceptibility to infections [88]. Although acute postpartum maternal infection did not adversely affect 
milk volume and milk composition in Peruvian women [93,94], the effect of sub-clinical chronic 
infections on zinc metabolism during lactation is unknown. 
At this time, it is not known if there is a dietary threshold below which zinc homeostatic 
adjustments cannot be made to support a healthy pregnancy and lactation period. Comprehensive 
longitudinal studies of zinc homeostatic adjustments of populations chronically consuming low zinc 
diets are needed to determine if such a threshold exists and, if so, how it is affected by other dietary 
and environmental factors. 
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